FDA fully approves Leqembi, first drug to slow progression of Alzheimer's disease

The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit. #news #alzheimer #health Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app. Subscribe to “CBS Mornings” on YouTube: https://www.youtube.com/CBSMornings Watch CBS News: http://cbsn.ws/1PlLpZ7c Download the CBS News app: http://cbsn.ws/1Xb1WC8 Follow "CBS Mornings" on Instagram: https://bit.ly/3A13OqA Like "CBS Mornings" on Facebook: https://bit.ly/3tpOx00 Follow "CBS Mornings" on Twitter: https://bit.ly/38QQp8B Subscribe to our newsletter: http://cbsn.ws/1RqHw7T​ Try Paramount+ free: https://bit.ly/2OiW1kZ For video licensing inquiries, contact: licensing@veritone.com